RGNX
REGENXBIO Inc.
Company Overview
| Mkt Cap | $664.77M | Price | $12.77 |
| Volume | 473.91K | Change | -0.39% |
| P/E Ratio | -2.9 | Open | $12.82 |
| Revenue | $83.3M | Prev Close | $12.82 |
| Net Income | $-227.1M | 52W Range | $5.04 - $13.93 |
| Div Yield | N/A | Target | $29.27 |
| Overall | 57 | Value | 60 |
| Quality | 47 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyREGENXBIO Inc. (RGNX) is a leading Healthcare company in the Biotechnology industry, currently trading at $12.77 with a market capitalization of $664.77 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows RGNX with a volume of 474K shares. The stock opened down 0.00% from yesterday's close of $12.82. Current analyst estimates project earnings of $-2.43 per share for this year, with next year targeting $-2.59.
RGNX demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for RGNX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 129.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGNX | $12.77 | -0.4% | 473.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |